Informations sur le produit
- (.+-.)-Verapamil
- 2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile
- 2-(3,4-Dimethoxyphenyl)-5-[[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino]-2-(propan-2-yl)pentanenitrile
- 2-(3,4-Dimethoxyphenyl)-5-[[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino]-2-isopropylpentanenitrile
- 5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxy phenyl)-2-isopropylvaleronitrile
- Cp 16533-1
- D 365
- Iproveratril
- Lekoptin
- Nsc 272306Na
- Voir d'autres synonymes
- R,S-Verapamil
- VPL
- Valeronitrile, 5-[(3,4-dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropyl-
- Verapamilo
- dl-Verapamil
- α-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-α-(1-methylethyl)benzeneacetonitrile
- Benzeneacetonitrile, α-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-α-(1-methylethyl)-
Verapamil is a calcium antagonist that blocks the influx of extracellular calcium and inhibits the release of calcium from intracellular storage sites. Verapamil may be used to treat hypertension, angina pectoris, and arrhythmias. This drug is also used as a diagnostic agent in studies of the cardiovascular system. Verapamil has been shown to reduce ventricular systolic dysfunction and cardiovascular morbidity in patients with chronic heart failure. The elimination half-life of verapamil ranges from 5 to 8 hours, depending on dose. It is eliminated primarily by renal excretion with less than 1% being metabolized in the liver.
Propriétés chimiques
Question d’ordre technique sur : 3D-FV02354 Verapamil
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages